Therefore, we systemically conducted this meta‐analysis to determine whether immunochemotherapy was superior to chemotherapy in the first‐line treatment of ES‐SCLC, especially for brain metastases, liver metastases, PD‐L1, and LDH subgroups. The gene discussed is CD274; the disease is small cell lung carcinoma.